Navigation Links
VIVUS to Present at Lazard Capital Markets Healthcare Conference
Date:11/11/2009

MOUNTAIN VIEW, Calif., Nov. 11 /PRNewswire-FirstCall/ -- VIVUS, Inc. (Nasdaq: VVUS) today announced that Timothy Morris, chief financial officer, will present an overview of the company at the Lazard Capital Markets 6th Annual Healthcare Conference.

The VIVUS presentation will take place at The St. Regis in New York, NY on Wednesday, November 18, 2009 at 1:45 p.m. ET. A live webcast and 30-day archive of the presentation will be available at http://ir.vivus.com.

About VIVUS

VIVUS is a biopharmaceutical company developing innovative, next-generation therapies to address unmet needs in obesity, diabetes and sexual health. The company's lead product in clinical development, Qnexa(TM), has recently completed phase 3 clinical trials for the treatment of obesity. Qnexa is also in phase 2 clinical development for the treatment of type 2 diabetes. In the area of sexual health, VIVUS is in phase 3 development with avanafil, a potentially best-in-class PDE5 inhibitor, and in phase 2 development of Luramist(TM) for the treatment of hypoactive sexual desire disorder (HSDD) in women. MUSE® (alprostadil), a first generation therapy for the treatment of ED, is already on the market and generating revenue for VIVUS. For more information about the company, please visit www.vivus.com.

    CONTACT:

    VIVUS, Inc.                 Investor Relations: The Trout Group
    Timothy E. Morris                               Brian Korb
    Chief Financial Officer                         646-378-2923
    650-934-5200
                                Media Relations:    Pure Communications, Inc.
                                                    Dan Budwick
                                                    973-271-6085

'/>"/>
SOURCE VIVUS, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Results From Phase 3 EQUATE Trial of VIVUS Qnexa Highlighted at European Congress on Obesity
2. VIVUS Initiates Open Label Safety Study of Avanafil for Erectile Dysfunction
3. Data on VIVUS Qnexa to be Featured at European Association for the Study of Diabetes Annual Meeting
4. VIVUS Announces Promotion of Peter Tam to President
5. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
6. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
7. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
8. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
9. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
10. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
11. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... , Sept. 22, 2014 /PRNewswire/-- CANTEL MEDICAL CORP. (NYSE: ... quarter and fiscal 2014 ended July 31, 2014 on Monday, ... call to discuss the results at 11:00 AM ET. Participating ... Chairman; Andrew A. Krakauer , President and CEO; ... Craig A. Sheldon , Senior Vice President, CFO and Treasurer; ...
(Date:9/22/2014)... 2014  Inovio Pharmaceuticals, Inc. (NASDAQ: ... phase I clinical trial in patients with aerodigestive ... and immunogenicity of INO-3106. This immunotherapy targets human ... cancers. Aerodigestive cancers affect the lips, ... of the esophagus and windpipe. The unmet need ...
(Date:9/22/2014)... , Sept. 22, 2014  Seres Health, a ... to the human microbiome, today announced that it has ... 2014,s Fierce 15 biotechnology companies, designating it as one ... industry.  "Amid a great deal of ... its focus and commitment to practical therapeutic development," says ...
Breaking Medicine Technology:Cantel Medical Corp. To Hold Conference Call To Discuss Results For Its Fourth Quarter And Fiscal 2014 Ended July 31, 2014 2Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 2Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 3Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 4Seres Health Named a "Fierce 15" Biotech Company for 2014 2
... Morgan honored with The TIME Award for ... National Council for Prescription Drug Programs (NCPDP), a not-for-profit ... services industry, awarded Kay Morgan, Senior Vice President of Drug ... / Gold Standard , with its highest honor, The TIME ...
... 17, 2012 SurgLine International, Inc. (SGLN.PK) ... stated that the Company has acquired Eden Surgical Technologies, ... a distributor of trauma products with extensive products focused ... pleased to announce today that we have acquired Eden ...
Cached Medicine Technology:Elsevier / Gold Standard's Kay Morgan Awarded NCPCP Highest Honor 2Elsevier / Gold Standard's Kay Morgan Awarded NCPCP Highest Honor 3SurgLine International, Inc. to Expand its Trauma Product Line With Completion of Acquisition 2
(Date:9/22/2014)... Manhattan residents who suffer with hip ... hip , which could be bursitis now have a ... now offered at New York Dynamic Neuromuscular Rehabilitation Center. ... occurs when the trochanteric bursa becomes irritated or inflamed. ... between the iliotibial band and the greater trochanter. Most ...
(Date:9/22/2014)... HealthDay Reporter MONDAY, Sept. ... children aged 6 months and older be vaccinated for the ... their influenza vaccine recommendations to advise that the youngest kids ... The AAP also wants parents of children aged 2 to ... instead of the flu shot if it,s readily available. ...
(Date:9/22/2014)... patients undergoing breast cancer surgery require additional operations because ... in the initial operation. However, researchers at Brigham and ... developed that will help surgeons better distinguish cancerous breast ... repeat operations. , The study is ... the Proceedings of the National Academy of Sciences ...
(Date:9/22/2014)... Malaysia today became a founding partner in the Global ... to promoting young talent in science, technology, engineering and ... New York Academy of Sciences (NYAS), Malaysian Prime Minister ... Monday Sept. 22. , With the goal of developing ... countries by 2020, the initiative will create a host ...
(Date:9/22/2014)... (September 22, 2014) South Asians living in Canada ... the rate of diabetes compared with while people, McMaster ... today in the Canadian Medical Association Journal (CMAJ ... , One of the fastest-growing ethnic groups in ... Asian people living in Canada, comprising about three percent ...
Breaking Medicine News(10 mins):Health News:DNR Clinic Offers Hip Bursitis Treatment in Manhattan 2Health News:DNR Clinic Offers Hip Bursitis Treatment in Manhattan 3Health News:Pediatricians Urge Flu Vaccine for All Kids 6 Months and Older 2Health News:Pediatricians Urge Flu Vaccine for All Kids 6 Months and Older 3Health News:The fine line between breast cancer and normal tissues 2Health News:Growing scientists: World's future jobs are rooted in STEM 2Health News:Growing scientists: World's future jobs are rooted in STEM 3Health News:Higher risk of heart disease for South Asians in Canada 2
... Oxygen Funding Reductions,which could ,Jeopardize Care, and ,Make ... Draws Widespread Support Among Home Oxygen Community, ... Care (CQRC) - a coalition of the 12 ... care and services to approximately,650,000 chronically ill home ...
... the messages of national No Smoking Day on 12th March ... left to you, then recent research from the Peninsula Medical ... think again. , Extensive research carried out by Dr Iain ... between smoking and psychological wellbeing. Dr Lang and colleagues used ...
... Store into Living Classroom Focused on ... Children,s ... SVU ) company, today announced the official launch of a significant,health ... obesity impacting one in every three U.S. children,according to the Center ...
... 6 Accident Fund Insurance Company,of America recognizes ... its,President,s Club Award., (Logo: http://www.newscom.com/cgi-bin/prnh/20070827/CLM117LOGO ... to a select number of independent,insurance agencies that ... performance based on volume and profitability goals for ...
... Global Healthcare,Inc. today announced the addition of ... of overseas medical facilities, bringing its total ... Hospital, Gleneagles Hospital and East Shore Hospital,all ... have agreed to,treat Companion Global Healthcare,s U.S. ...
... hereditary disease where the immune system attacks the bodys ... project, coordinated by Professor Olle Kmpe at Uppsala university, ... opens new possibilities of understanding both APS-1 and other ... American journal The New England Journal of Medicine. , ...
Cached Medicine News:Health News:Home Oxygen Community Applauds Senators Olympia Snowe and Susan Collins for Joining Bi-Partisan Effort to Formally Oppose Proposed Cuts to Medicare's Home Oxygen Benefit 2Health News:Albertsons Officially Launches Healthy Eaters(TM) Field Trip Program 2Health News:Albertsons Officially Launches Healthy Eaters(TM) Field Trip Program 3Health News:Three Hospitals in Singapore Join Companion Global Healthcare Network 2Health News:New protein discovery helps researchers understand autoimmune diseases 2
Rotating 360 degrees, 3 mm x 7 mm bite....
45 degree, forward 3 mm, 4 mm x 5 mm cup, length of shaft 140 mm, overall length 8.3 inches....
20 mm. Plastic, methylmethacrylate. Supplied sterile....
Small right. Teflon orbital plates....
Medicine Products: